Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002038763 | SCV002309404 | benign | not provided | 2023-02-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004044809 | SCV004963217 | likely benign | Inborn genetic diseases | 2024-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV002038763 | SCV005194502 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003968691 | SCV004785917 | likely benign | TCF20-related disorder | 2023-03-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |